Our Mission

“Funding research to develop new drug therapies and treatments for Hodgkin’s lymphoma and to improve the quality of life for patients and their families managing Hodgkin’s.”

 

 

 

 

 

About the Foundation

 

A fund was established shortly after Adam passed away in April 2007 at Memorial Sloan-Kettering Cancer Center. We have established this Foundation in May 2010 to give us the latitude to fund other institutions for Hodgkin’s research. The Adam R. Spector Foundation is a 501(c)(3) nonprofit organization registered in Pennsylvania.

To date we have provided funding to Dr. David Straus at Memorial Sloan-Kettering for his research in long-term survivorship, which is not always positive and can be associated with toxicities. Another study was a drug therapy for stage I/II Hodgkin’s and pre-treatment prognostic factors with interim PET scans.

We have donated to the Adam Spector Fund for Hodgkin’s Research at Children’s Hospital of Philadelphia under the leadership of Dr. Richard Aplenc. Dr. Kim Nichols is the principal investigator for the study that we are helping to fund. Her laboratory is interested in understanding the host genetic factors that protect against infection with Epstein Barr virus (EBV), a virus associated with the development of several human diseases, including Hodgkin’s lymphoma. These dedicated clinician researchers strive to improve the treatment and outcome of patients with Hodgkin’s.

We are helping to fund a grant from Dr. Terzah Horton from Texas Childrens’s Hospital affiliated with Baylor College of Medicine to identify prognostic biomarkers in pediatric Hodgkin’s.